Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices

altRx vs ro vs Sprout: Three Ways to Brand-Name GLP-1s

Last updated: Sep 1, 2026

Medically reviewed on

How we review

We may earn a commission from links on this page - it never affects our rankings (how we stay objective).

Here’s the short version

Most GLP-1 comparisons are about compounded medication - this one is about the real branded pens, because these are the three providers in our ranking that publish brand-name pricing, and they sell it three completely different ways. altRx posts flat cash prices next to its $89 compounded plan: Ozempic $1,149, Zepbound $1,249, Wegovy $1,579 a month, with Buy Now, Pay Later. ro sells a membership ($39 the first month, then $74-$149/month) with the medication billed separately - Wegovy pill from $149/month, Zepbound KwikPen from $299 the first month - and it's the one route here where insurance, if it covers you, changes the math completely. Sprout is compounded-first from $99/month on its 12-month plan ($149 month to month) but keeps brand-name Wegovy on the shelf at $1,799 for anyone set on the branded pen, and ships prescriptions within 2 days.

altRx logo
Licensed US telehealth

Most Comprehensive GLP-1 Medication Access

Visit altRx
ro logo
Licensed US telehealth

Simple Online Weight Loss Care

Visit ro
Sprout logo
Licensed US telehealth

Save $200 on your first month

Visit Sprout

altRx vs ro vs Sprout: side by side

Real published prices and terms - the differences that actually decide this matchup.

altRxroSprout
Semaglutide$89/mo (reg. $199), flat at every doseBrand-name Wegovy: pill from $149/mo, pen from $199 - plus membershipfrom $99/mo compounded on the 12-month plan ($149/mo monthly); brand-name Wegovy from $1,799
Tirzepatide$149/mo (reg. $299)Brand-name Zepbound KwikPen from $299 first mo, then $399-449from $149/mo on the 12-month plan ($199/mo monthly)
Billing & commitmentMonthly - pause or cancel anytime; Buy Now, Pay LaterMembership ($39 first mo, then $74-$149/mo) + medication billed separately - cash or insurance12-month plan billed upfront, 6- and 3-month plans, or monthly with no commitment
ShippingFree nationwide deliveryIn-house pharmacy with home deliveryPrescriptions shipped within 2 days
SupportLicensed provider review (physician, PA, or NP)Board-certified provider consultations; ongoing dose adjustmentsPersonalized, provider-guided treatment plans
Guarantee / refund---
StandoutBrand-name shelf: Ozempic $1,149 · Zepbound $1,249 · Wegovy $1,579Insurance can cut the medication costBrand-name Wegovy shelf + 2-day fulfillment

Our verdict

The buying structure decides this one, not the sticker. Any chance your insurance covers GLP-1s: start with ro - membership plus a copay can undercut every cash price on this page. Paying cash and want one flat, published number: altRx - its brand shelf is the cheapest flat-rate Wegovy here and BNPL spreads it, with the $89 compounded plan as the fallback lane. Want compounded speed with a brand option in reserve: Sprout - 2-day fulfillment and the same price at any dose, with the Wegovy shelf there if you upgrade later. Formats and billing differ enough between these three that the right answer is genuinely different per person - check the current price on each site before deciding.

altRx vs ro vs Sprout: FAQs

Which has the cheapest brand-name Wegovy?

The published structures differ, so compare carefully: altRx lists brand-name Wegovy at a flat $1,579/month cash. Sprout lists it from $1,799/month. ro prices the Wegovy pill from $149/month and the pen from $199 at intro rates (rising to $299-$399/month after), plus its $39-to-$149/month membership - and where insurance covers the medication, ro's route can be the cheapest by far.

Do all three also offer compounded semaglutide?

altRx ($89/month promotional, flat at every dose) and Sprout (from $99/month on the 12-month plan, $149/month with no commitment) publish flat compounded semaglutide rates. ro's published weight-loss pricing centers on brand-name medication plus its Body membership rather than a flat compounded plan.

How does ro's membership pricing actually work?

Two separate charges: the Ro Body membership - $39 the first month, then $74/month on an annual prepaid plan up to $149/month - and the medication itself, billed separately either through insurance or cash-pay at ro's published rates. That's different from altRx and Sprout, where one monthly price includes the program.

Which delivers fastest?

Sprout ships prescriptions within 2 days of approval. altRx offers free nationwide delivery on standard timelines, and ro fulfills through its own in-house pharmacy with home delivery.

Break it down two at a time

The head-to-head comparisons between these providers.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)